| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/19/2002 | WO2002072597A2 Helicomimetics and stabilized lxxll peptidomimetics |
| 09/19/2002 | WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes |
| 09/19/2002 | WO2002018341A3 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 09/19/2002 | WO2002014350A3 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
| 09/19/2002 | WO2002010192A3 Somatostatin analogues |
| 09/19/2002 | WO2001025264A9 Substituted phosphinate based peptide derivatives |
| 09/19/2002 | US20020133001 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/19/2002 | US20020132988 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 09/19/2002 | US20020132974 Material composed of amino acid sequences for use in diagnosis and treatment of nervous system and brain disorders |
| 09/19/2002 | US20020132973 Peptide parathyroid hormone analogs |
| 09/19/2002 | US20020132776 Inhibitors of transglutaminase |
| 09/19/2002 | US20020132765 Powerful activity when administered orally and by injection so that they can be used in a hospital environment via injection, followed by an oral ambulatory treatment |
| 09/19/2002 | US20020132763 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 09/19/2002 | US20020132762 Contacting the antibiotic with a divalent metal ion and an organic solvent, to extract the lipopeptide antibiotic into the solvent; and contacting the extract of the lipopeptide antibiotic with acid. |
| 09/19/2002 | CA2702192A1 Igf antagonist peptides |
| 09/19/2002 | CA2473979A1 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | CA2470152A1 Transfection complexes comprising a novel peptide as cell surface receptor binding component |
| 09/19/2002 | CA2441210A1 Novel peptide ligands of leukocyte integrins |
| 09/19/2002 | CA2440208A1 Tumour targeting prodrugs activated by metallo matrixproteinases |
| 09/19/2002 | CA2439735A1 Igf antagonist peptides |
| 09/19/2002 | CA2439498A1 Somatostatin antagonists |
| 09/19/2002 | CA2439236A1 Immuno-enhancing agent |
| 09/18/2002 | EP1241259A1 Peptide having pronociceptive properties |
| 09/18/2002 | EP1241257A1 Novel tachykinin-like polypeptides and use thereof |
| 09/18/2002 | EP1240337A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 09/18/2002 | EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 09/18/2002 | EP1240193A2 Peptide fragments of colostrinin |
| 09/18/2002 | EP1240182A2 Daptomycin analogs and their use as antibacterial agents |
| 09/18/2002 | EP1240181A2 Daptomycin analogs as antibacterial agents |
| 09/18/2002 | EP1240180A2 Peptides designed for the diagnosis and treatment of rheumatoid arthritis |
| 09/18/2002 | EP1239887A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 09/18/2002 | EP1239867A2 Methods for treating and preventing damage to mucosal tissue |
| 09/18/2002 | EP1239866A1 INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| 09/18/2002 | EP0921808B1 Non-aqueous polar aprotic peptide formulations |
| 09/18/2002 | EP0904285B1 Cyclic adhesion inhibitors |
| 09/18/2002 | EP0861265B1 use of CASEIN FRAGMENTS as GROWTH PROMOTer |
| 09/18/2002 | CN1370181A Effectors of dipeptidyl peptidase IV for topical use |
| 09/18/2002 | CN1370078A Prion protein peptides and uses thereof |
| 09/17/2002 | US6451972 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 09/17/2002 | US6451971 Polypeptide cell adhesion inhibitors; antimetastasis and anticarcinogenic agents |
| 09/17/2002 | US6451969 Polypeptide binds lectin; inhibits carbohydrate binding to selectin |
| 09/17/2002 | US6451968 Hoogsteen type base pairing in triplex motif; diagnosis; heat resistance; detection of point mutations, restriction enzyme sites, and transcription inhibition |
| 09/17/2002 | US6451776 Water soluble prodrugs of hindered alcohols |
| 09/17/2002 | CA2278878C Very large scale immobilized peptide synthesis |
| 09/17/2002 | CA2221129C An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine |
| 09/17/2002 | CA2213001C Isolated nucleic acid molecule encoding peptides which form complexes with mhc molecule hla-cw*1601 and uses thereof |
| 09/17/2002 | CA2172989C Conotoxin peptides |
| 09/17/2002 | CA2150371C Materials and methods for control of pests |
| 09/17/2002 | CA2122036C Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 09/17/2002 | CA2080272C Cyclic vasoactive peptides |
| 09/17/2002 | CA2045473C Compositions for treating ischemia-related neuronal damage |
| 09/12/2002 | WO2002070698A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 09/12/2002 | WO2002070555A2 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | WO2002070547A1 Template-fixed peptidomimetics with antimicrobial activity |
| 09/12/2002 | WO2002070018A2 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
| 09/12/2002 | WO2002069930A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | WO2002069902A2 Cyclosporins for the treatment of respiratory diseases |
| 09/12/2002 | WO2002069885A2 Anti-invasive and anti-angiogenic compositions and methods for treating brain tumors and other diseases |
| 09/12/2002 | WO2002069691A2 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2001071346A3 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 09/12/2002 | WO2001019852A3 Methods of peptide preparation |
| 09/12/2002 | WO2000075167A3 Phosphorylation assays |
| 09/12/2002 | US20020128470 Purification process |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020128195 Hydrophilic polymer covalently and reversibly linked to amine-containing ligand through dithiobenzyl linkage; improves blood circulation time |
| 09/12/2002 | US20020127629 Imaging of enzymatic activity |
| 09/12/2002 | US20020127198 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | DE10109813A1 Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen Tumor antigen peptide from human MDM2 proto-oncogene |
| 09/12/2002 | CA2743731A1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | CA2445018A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | CA2439990A1 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/12/2002 | CA2439832A1 Cyclosporins for the treatment of respiratory diseases |
| 09/12/2002 | CA2439682A1 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 09/12/2002 | CA2439579A1 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
| 09/12/2002 | CA2439178A1 Template-fixed peptidomimetics with antimicrobial activity |
| 09/12/2002 | CA2438326A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/11/2002 | EP1238109A2 Methods and kits for discovery of rna-binding antimicrobials |
| 09/11/2002 | EP1237908A2 Ligands for a target molecule and method for identifying them |
| 09/11/2002 | EP1237907A2 Complementary peptide ligands generated from the human genome |
| 09/11/2002 | EP1237572A2 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 09/11/2002 | EP1237564A1 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 09/11/2002 | EP0853484B1 Novel mu opioid receptor ligands: agonists and antagonists |
| 09/11/2002 | EP0603399B1 Endothelin-antagonizing peptide |
| 09/11/2002 | CN1368892A Sustained release formulation of peptide |
| 09/10/2002 | US6448391 Ubiquitin-lytic peptide fusion gene constructs with enhanced stability and gene expression |
| 09/10/2002 | US6448374 Production of phosphopeptides from casein |
| 09/10/2002 | US6448224 Antibiotics and methods of using the same |
| 09/10/2002 | US6448031 Catalyzed by chymotrypsin in a reaction medium comprising 1-butanol |
| 09/10/2002 | US6447992 Method for serological typing using type-specific antigens |
| 09/10/2002 | US6447766 Deamidated chemokines |
| 09/10/2002 | CA2258661C Synthetic phosphopeptides for treating bone diseases |
| 09/10/2002 | CA2108678C Production of phosphopeptides from casein |
| 09/06/2002 | WO2002068586A2 Hiv/fiv protease inhibitors |
| 09/06/2002 | WO2002068585A2 Tip39 polypeptides |
| 09/06/2002 | WO2002068469A2 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | WO2002068461A2 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | WO2002068456A1 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs |
| 09/06/2002 | WO2002067974A1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |